Combination Assessment Trial of COVID-19 Vaccines (COMBAT-COVID)

Clinical trial NCT05162482 · UNKNOWN

Trial details

NCT number: NCT05162482
Sponsor: Aga Khan University Hospital, Pakistan
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

COVID 19 Vaccine

Start date: 2022-03-01
Primary completion: 2024-06-30
Enrollment: 1680

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.